China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Down 7.3 %

Shares of NYSE CPHI opened at $0.30 on Friday. The stock has a fifty day moving average price of $0.37 and a two-hundred day moving average price of $0.47. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. China Pharma has a 1 year low of $0.27 and a 1 year high of $2.70.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.